tirzepatide caremark https://bit.ly/45UTcvJ 🚨 Attention Zepbound Users! 🚨 Starting July 1, 2025, CVS will drop coverage for Zepbound (tirzepatide) and switch to Wegovy (semaglutide) as the preferred weight-loss medication. ⚠️ Why this matters 🚨 CVS Caremark “Tirzepatide Product”

According to mounting research, insulin resistance may impair cognitive functioning by resulting in mitochondrial malfunction, changes in synaptic plasticity, development of A plaques, hyperphosphorylation of Tau, among other things (Jayaraman and Pike, 2014

Make an appointment by clicking the button below

A SURPASS-2 trial compared tirzepatide to semaglutide in patients already taking metformin, and found that tirzepatide led to greater reductions in HbA1c (a measure of average blood sugar levels) and body weight compared to semaglutide

By the end of week eight, approximately 70-80% of users report clinically meaningful appetite suppression

It also slows gastric emptying , meaning food stays in your stomach longer, helping you feel fuller for an extended period

Your PlexusDx provider can adjust your protocol if symptoms become problematic